Skip to main content

Currently Skimming:

Looking Forward: Forum Activities in 2011
Pages 8-9

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 8...
... The workshop will examine ways to advance regulatory science for MCM development for chemical, biological, radiological/nuclear, and emerging infectious disease threats and iden tify scientific opportunities to improve, simplify, or speed MCM development and improve the predictability and success rate of candidate MCMs. The Global Threat of Multidrug-Resistant Tuberculosis (India and China)
From page 9...
... An additional meeting addressing approaches for enhanced public engagement in the clinical trial enterprise is also planned for 2011. June 23 April 21 Workshop: Breakthrough November 30 Discussion Series: Business Models: Drug Discussion Series: A Conversation Science at FDA: Challenges Development for Rare with Tony Fauci and Opportunities and Neglected Diseases 2008 February 20–21 June 23–24 Discussion Series: Comparative Symposium: Diseases and Individualized Effectiveness (Forum Meeting #9)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.